Publicacións en colaboración con investigadores/as de Instituto de Oftalmología Aplicada de Valladolid (2)

2013

  1. Adalimumab (Tumor necrosis factor-blocker) reduces the expression of glial fibrillary acidic protein immunoreactivity increased by exogenous tumor necrosis factor alpha in an organotypic culture of porcine neuroretina

    Molecular Vision, Vol. 19, pp. 894-903

  2. Histology and immunochemistry evaluation of autologous translocation of retinal pigment epithelium-choroid graft in porcine eyes

    Acta Ophthalmologica, Vol. 91, Núm. 2